Assembly Biosciences Inc (ASMB)
14.90
+0.21
(+1.43%)
USD |
NASDAQ |
Oct 04, 16:00
14.25
-0.65
(-4.36%)
After-Hours: 20:00
Assembly Biosciences Shareholders Equity (Annual): 41.10M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 41.10M |
December 31, 2022 | 82.66M |
December 31, 2021 | 168.93M |
December 31, 2020 | 240.58M |
December 31, 2019 | 273.22M |
December 31, 2018 | 210.65M |
December 31, 2017 | 113.12M |
December 31, 2016 | 79.88M |
Date | Value |
---|---|
December 31, 2015 | 118.74M |
December 31, 2014 | 58.57M |
December 31, 2013 | 24.49M |
December 31, 2012 | 17.81M |
December 31, 2011 | 34.53M |
December 31, 2010 | 11.63M |
December 31, 2009 | -13.36M |
December 31, 2008 | -9.457M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
41.10M
Minimum
2023
273.22M
Maximum
2019
161.30M
Average
168.93M
Median
2021
Shareholders Equity (Annual) Benchmarks
ADMA Biologics Inc | 135.21M |
Sensus Healthcare Inc | 48.84M |
Tenon Medical Inc | 0.778M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -0.1115M |